Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127459223 | 12745922 | 3 | F | 20160714 | 20160916 | 20160915 | 20160928 | EXP | IT-MINISAL02-373333 | IT-TEVA-692273ACC | TEVA | 48.52 | YR | F | Y | 0.00000 | 20160928 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127459223 | 12745922 | 1 | PS | ZOLPIDEM TARTRATE. | ZOLPIDEM TARTRATE | 1 | Oral | 2400 MG TOTAL | U | U | 76410 | 2400 | MG | ORAL DROPS | |||||
| 127459223 | 12745922 | 2 | SS | XANAX | ALPRAZOLAM | 1 | Oral | 30 MG TOTAL | U | U | 0 | 30 | MG | ORAL DROPS | |||||
| 127459223 | 12745922 | 3 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127459223 | 12745922 | 1 | Drug abuse |
| 127459223 | 12745922 | 2 | Drug abuse |
| 127459223 | 12745922 | 3 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127459223 | 12745922 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127459223 | 12745922 | Disorganised speech | |
| 127459223 | 12745922 | Drop attacks | |
| 127459223 | 12745922 | Drug abuse | |
| 127459223 | 12745922 | Intentional self-injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |